MLTX vs ENOV

Comparison between MoonLake Immunotherapeutics - Class A (MLTX, Company) and Enovis Corp (ENOV, Company).

Both MLTX and ENOV are from the Healthcare sector.

5-Year PerformanceMLTX has outperformed ENOV, delivering a return of +13.3% compared to -21.3%

MLTX vs ENOV - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MLTX(COMPANY)	ENOV(COMPANY)
Market Cap	$1.36B	$1.36B
Max Drawdown	90.22%	84.46%
Sharpe Ratio	0.60	-0.34
5Y Beta	0.96	1.38
Industry	Biotechnology	Medical Devices
P/E Ratio	-5.32	-1.19
Forward P/E	N/A	6.10
PEG Ratio	-0.03	-0.03
Debt to Equity	38.98%	89.78%
Free Cash Flow Yield	-16.49%	2.64%

Market Cap

MLTX

$1.36B

Winner

ENOV

$1.36B

Max Drawdown

MLTX

90.22%

Winner

ENOV

84.46%

Sharpe Ratio

Winner

MLTX

0.60

ENOV

-0.34

5Y Beta

Winner

MLTX

0.96

ENOV

1.38

Industry

MLTX

Biotechnology

ENOV

Medical Devices

P/E Ratio

Winner

MLTX

-5.32

ENOV

-1.19

Forward P/E

MLTX

N/A

ENOV

6.10

PEG Ratio

Winner

MLTX

-0.03

ENOV

-0.03

Debt to Equity

Winner

MLTX

38.98%

ENOV

89.78%

Free Cash Flow Yield

MLTX

-16.49%

Winner

ENOV

2.64%

MLTX vs ENOV - Historical Returns

Returns include dividend reinvestment.

Period	MLTX	ENOV
1 month	+5.94%	-0.25%
3 months	+2.53%	-0.71%
6 months	+32.98%	-18.07%
1 year	-59.21%	-32.01%
5 years(CAGR)	+13.27%	-21.27%
10 years(CAGR)	N/A	-6.82%
Max(CAGR)	+11.03%	-2.31%

Winner

MLTX

+5.94%

ENOV

-0.25%

Winner

MLTX

+2.53%

ENOV

-0.71%

Winner

MLTX

+32.98%

ENOV

-18.07%

MLTX

-59.21%

Winner

ENOV

-32.01%

5Y(CAGR)

Winner

MLTX

+13.27%

ENOV

-21.27%

10Y(CAGR)

MLTX

N/A

ENOV

-6.82%

Max(CAGR)

Winner

MLTX

+11.03%

ENOV

-2.31%

MLTX vs ENOV - Annual Returns (2008 - 2026)

Returns include dividend reinvestment.

Year	MLTX	ENOV
2026	+59.58%	-10.90%
2025	-75.40%	-39.86%
2024	-9.07%	-20.85%
2023	+447.76%	+2.98%
2022	+5.85%	-33.04%
2021	-8.76%	+24.04%
2020	+8.39%	+3.32%
2019	N/A	+73.98%
2018	N/A	-47.51%
2017	N/A	+7.37%
2016	N/A	+51.35%
2015	N/A	-55.22%
2014	N/A	-18.39%
2013	N/A	+51.68%
2012	N/A	+42.83%
2011	N/A	+51.89%
2010	N/A	+48.71%
2009	N/A	+11.90%
2008	N/A	-50.52%

MLTX vs ENOV Drawdown Comparison

The maximum drawdown for MLTX was -90.22%, occurring on Sep 29, 2025. This drawdown has not yet recovered.

The maximum drawdown for ENOV was -84.46%, occurring on Jul 1, 2026. This drawdown has not yet recovered.

The current MLTX drawdown is -70.14%. The current ENOV drawdown is -81.68%.

Rank	MLTX	ENOV
#1	-90.22% Feb 12, 2024 - Sep 29, 2025	-84.46% Jul 1, 2014 - Jul 1, 2026
#2	-64.60% Apr 5, 2022 - Feb 7, 2023	-80.41% Aug 4, 2008 - Aug 1, 2011
#3	-41.80% Oct 5, 2023 - Dec 27, 2023	-31.82% Aug 1, 2011 - Nov 8, 2011
#4	-25.65% Feb 18, 2021 - Apr 5, 2022	-31.40% Feb 16, 2012 - Sep 20, 2012
#5	-19.79% Mar 8, 2023 - Apr 24, 2023	-12.59% Mar 15, 2013 - May 17, 2013
#6	-18.38% Jul 28, 2023 - Oct 5, 2023	-11.98% Dec 7, 2011 - Jan 10, 2012
#7	-15.06% Dec 27, 2023 - Feb 9, 2024	-11.25% May 30, 2008 - Jun 24, 2008
#8	-14.12% Apr 24, 2023 - May 4, 2023	-10.29% Jan 22, 2014 - Feb 13, 2014
#9	-12.27% Jun 9, 2023 - Jun 26, 2023	-10.10% Oct 17, 2012 - Nov 26, 2012
#10	-7.95% Jul 19, 2023 - Jul 26, 2023	-9.83% Nov 16, 2011 - Dec 5, 2011
#11	-7.48% Jul 5, 2023 - Jul 14, 2023	-8.86% Jan 18, 2012 - Feb 6, 2012
#12	-5.83% Oct 22, 2020 - Dec 1, 2020	-8.53% Jul 22, 2008 - Aug 4, 2008
#13	-5.45% May 10, 2023 - May 25, 2023	-8.02% May 15, 2008 - May 29, 2008
#14	-5.45% Dec 31, 2020 - Jan 8, 2021	-7.51% Jan 31, 2013 - Mar 5, 2013
#15	-4.78% Jan 8, 2021 - Feb 11, 2021	-6.84% Jul 11, 2008 - Jul 21, 2008